Stanford University
Showing 51-60 of 155 Results
-
Ahmer Irfan, MD
Clinical Assistant Professor, Surgery - General Surgery
BioDr. Ahmer Irfan is a board-certified, fellowship-trained hepatobiliary surgeon with Stanford Health Care. He is also a clinical assistant professor in the Department of Surgery, Division of General Surgery at Stanford University School of Medicine.
Dr. Irfan cares for cancer affecting the liver, pancreas, biliary system, and gastrointestinal system, often treating complex and advanced cancers. He specializes in performing minimally invasive surgery to remove cancer using laparoscopic, robotic, and ablative techniques. He takes a compassionate approach to cancer care, working with patients and families to develop personalized treatment plans that align with their goals.
Dr. Irfan’s research focuses on improving outcomes for patients with liver, pancreatic, and gastrointestinal cancers through advances in surgical care. His work has explored how surgeons make treatment decisions and how health care systems can optimize patient support throughout the cancer journey. He has also studied the use of advanced surgical techniques, including robotic surgery and vascular reconstruction, to treat complex cancers safely.
Dr. Irfan has published his findings in leading peer-reviewed journals, including the International Journal of Cancer, Journal of the American College of Surgeons, and HPB. He has also shared his research and expertise at prestigious surgical meetings of the Americas Hepato-Pancreato-Biliary Association (AHPBA), International Hepato-Pancreato-Biliary Association (IHPBA), and Pancreas Club. His presentation topics have focused on innovations in hepato-pancreato-biliary surgery, complex cancer care, and surgical education.
Dr. Irfan is a member of AHPBA, IHPBA, and Royal College of Physicians and Surgeons of Glasgow (RCPSG). -
Stefanie S. Jeffrey, MD
John and Marva Warnock Professor, Emerita
Current Research and Scholarly InterestsDr. Jeffrey led the multidisciplinary team from the Schools of Medicine, Engineering, and Genome Technology Center that invented the MagSweeper, an automated device that immunomagnetically captures live circulating tumor cells (CTCs) from cancer patient blood for single cell analysis or culture. Her lab also works on microfluidic technologies for tumor cell capture, characterization, and growth - with the goal of defining individual patient response to newer biologically-based cancer therapies.
-
Mardi Karin, MD, FACS
Clinical Professor, Surgery - General Surgery
BioDr. Mardi R. Karin is a board certified surgeon with over 20 years of experience, specializing in breast surgery and is Clinical Professor of Surgery in Stanford University Department of Surgery, Section of Surgical Oncology. She was appointed the first Clinical Director of Breast Cancer Care at Stanford Cancer Center South Bay after the new cancer center opened and served in this role from 2016-2019. Dr. Karin specializes in the surgical treatment of breast diseases and cancer. In addition to providing outstanding care, her focus and leadership in breast cancer care includes improving coordinated care for breast cancer treatment both within the Cancer Center and the community.
Dr. Karin has extensive experience in breast surgery, including complex breast cancer skin and nipple sparing procedures in coordination with the plastic surgeon for immediate breast reconstruction and optimal appearance with excellent outcomes. She collaborates closely with Plastic and Reconstructive Surgery to provide the best options to patients, including Oncoplastics for optimal aesthetic appearance with breast conservation treatment, in addition to mastectomy with nipple sparing and immediate breast reconstruction. Her clinical research is focused on improving patient outcomes in different aspects of breast surgery, including nipple sparing mastectomy by utilizing MRI blood flow information to preserve important blood flow to reduce complications. She also is involved with advancing surgical techniques to decrease lymphedema rates after axillary lymph node dissection, with lymphatic preservation and possible LYMPHA procedure by the Plastic Reconstructive Microsurgeons. In addition, she works in close collaboration with Medical Oncology to offer the latest most advanced treatments for breast cancer. -
Electron Kebebew, MD, FACS
Harry A. Oberhelman, Jr. and Mark L. Welton Professor
Current Research and Scholarly InterestsDr. Kebebew’s translational and clinical investigations have three main scientific goals: 1) to develop effective therapies for fatal, rare and neglected endocrine cancers, 2) to identify new methods, strategies and technologies for improving the diagnosis and treatment of endocrine neoplasms and the prognostication of endocrine cancers, and 3) to develop methods for precision treatment of endocrine tumors.
